Smith Asset Management Group LP boosted its position in Chemed Corp. (NYSE:CHE) by 3.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 23,229 shares of the company’s stock after buying an additional 800 shares during the period. Smith Asset Management Group LP owned approximately 0.14% of Chemed Corp. worth $3,166,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in CHE. Norges Bank purchased a new stake in shares of Chemed Corp. during the fourth quarter worth about $40,455,000. Renaissance Technologies LLC boosted its stake in shares of Chemed Corp. by 72.3% in the first quarter. Renaissance Technologies LLC now owns 148,200 shares of the company’s stock worth $20,074,000 after buying an additional 62,200 shares during the period. Van Berkom & Associates Inc. boosted its stake in shares of Chemed Corp. by 5.7% in the second quarter. Van Berkom & Associates Inc. now owns 448,096 shares of the company’s stock worth $61,080,000 after buying an additional 24,104 shares during the period. Apex Capital Management boosted its stake in shares of Chemed Corp. by 18.6% in the first quarter. Apex Capital Management now owns 130,220 shares of the company’s stock worth $17,638,000 after buying an additional 20,440 shares during the period. Finally, Investec Asset Management LTD boosted its stake in shares of Chemed Corp. by 3.0% in the first quarter. Investec Asset Management LTD now owns 559,973 shares of the company’s stock worth $75,848,000 after buying an additional 16,304 shares during the period. 98.62% of the stock is owned by hedge funds and other institutional investors.

Chemed Corp. (NYSE:CHE) traded up 1.53% during trading on Thursday, reaching $141.93. 71,694 shares of the company traded hands. The company has a market capitalization of $2.30 billion, a P/E ratio of 22.51 and a beta of 1.14. The firm has a 50-day moving average price of $137.20 and a 200-day moving average price of $135.41. Chemed Corp. has a 52 week low of $124.77 and a 52 week high of $160.12.

Chemed Corp. (NYSE:CHE) last posted its quarterly earnings data on Monday, July 25th. The company reported $1.80 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.72 by $0.08. The company earned $290 million during the quarter, compared to analysts’ expectations of $393.50 million. Chemed Corp. had a net margin of 6.93% and a return on equity of 24.12%. The firm’s revenue for the quarter was up 2.2% on a year-over-year basis. During the same period in the prior year, the business posted $1.71 earnings per share. Analysts forecast that Chemed Corp. will post $7.25 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 2nd. Shareholders of record on Monday, August 15th were given a dividend of $0.26 per share. The ex-dividend date of this dividend was Thursday, August 11th. This is a boost from Chemed Corp.’s previous quarterly dividend of $0.24. This represents a $1.04 dividend on an annualized basis and a yield of 0.73%. Chemed Corp.’s dividend payout ratio is currently 16.51%.

A number of analysts have recently issued reports on CHE shares. RBC Capital Markets reissued a “sector perform” rating and issued a $162.00 price objective (up from $136.00) on shares of Chemed Corp. in a research note on Wednesday, July 27th. Zacks Investment Research cut shares of Chemed Corp. from a “buy” rating to a “hold” rating in a research note on Friday, July 29th. Royal Bank Of Canada increased their price objective on shares of Chemed Corp. from $136.00 to $162.00 and gave the stock a “sector perform” rating in a research note on Wednesday, July 27th. Finally, JMP Securities reissued a “hold” rating on shares of Chemed Corp. in a research note on Sunday, September 4th. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The company currently has a consensus rating of “Hold” and an average target price of $159.00.

In other news, VP Arthur V. Tucker, Jr. sold 3,089 shares of the company’s stock in a transaction on Thursday, August 4th. The shares were sold at an average price of $143.88, for a total transaction of $444,445.32. Following the completion of the sale, the vice president now owns 3,234 shares of the company’s stock, valued at $465,307.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, VP Arthur V. Tucker, Jr. sold 4,500 shares of the company’s stock in a transaction on Friday, August 5th. The stock was sold at an average price of $144.28, for a total transaction of $649,260.00. Following the sale, the vice president now directly owns 7,734 shares of the company’s stock, valued at approximately $1,115,861.52. The disclosure for this sale can be found here. Company insiders own 5.32% of the company’s stock.

About Chemed Corp.

Chemed Corporation operates and divests subsidiaries engaged in diverse business activities. The Company operates its business in two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

5 Day Chart for NYSE:CHE

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corp. (NYSE:CHE).

Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.